FollowMyHealth Patient Portal

Cynthia Cherfane, MD

Instructor, Medicine
Division of Gastroenterology

Specialty Areas

Gastroenterology
Inflammatory Bowel Disease

Board Certifications

Internal Medicine
Gastroenterology

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital

Languages

Arabic
French

Areas of Clinical Interest

Inflammatory bowel disease, ulcerative colitis, Crohn's disease, celiac disease, pouchitis.

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Gastrointestinal Center

4921 Parkview Place
St. Louis, MO 63110

Office Phone: 314-747-4236
Fax: 314-747-5871

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Office Phone: 314-747-4236
Fax: 314-747-5871

Education

Education

Fellowship, Gastroenterology, Hepatology and Nutrition: University of Pittsburgh Medical Center, Pittsburgh, PA 2017
Residency, Internal Medicine: University of Iowa Hospitals and Clinics, Iowa City, IA 2014
Medical Degree: Universite Saint Joseph, Beirut, Lebanon 2010

Publication & Research

Publication & Research

Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
Cherfane CE, Gessel L, Cirillo D, Zimmerman MB, Polyak S
Inflamm Bowel Dis. 2015 Aug; 21(8)1769-75. doi: 10.1097/MIB.0000000000000427.

PMID:
    25993688
    [PubMed - indexed for MEDLINE]
Related citations


A late presentation of a fatal disease: juvenile hemochromatosis.
Cherfane C, Lee P, Guerin L, Brown K
Case Rep Med. 2013; 2013875093. doi: 10.1155/2013/875093.

PMID:
    24106505
    [PubMed]
Related citations


Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
Cherfane CE, Hollenbeck RD, Go J, Brown KE
Am J Med. 2013 Nov; 126(11)1010-5. doi: 10.1016/j.amjmed.2013.07.013.

PMID:
    24054178
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Establishing and analyzing a large data base of IBD patients. Identifying non-invasive prognostic biomarkers and markers of response to therapy.